Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial
Rugo, H.S., Diéras, V., Gelmon, K.A., Finn, R.S., Slamon, D.J., Martin, M., Neven, P., Shparyk, Y., Mori, A., Lu, D.R., Bhattacharyya, H., Bartlett, C.H.u.a.n.g., Iyer, S., Johnston, S., Ettl, J., Harbeck, N.
Published in Annals of oncology (01.04.2018)
Published in Annals of oncology (01.04.2018)
Get full text
Journal Article
Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study
Han, H.S., Diéras, V., Robson, M., Palácová, M., Marcom, P.K., Jager, A., Bondarenko, I., Citrin, D., Campone, M., Telli, M.L., Domchek, S.M., Friedlander, M., Kaufman, B., Garber, J.E., Shparyk, Y., Chmielowska, E., Jakobsen, E.H., Kaklamani, V., Gradishar, W., Ratajczak, C.K., Nickner, C., Qin, Q., Qian, J., Shepherd, S.P., Isakoff, S.J., Puhalla, S.
Published in Annals of oncology (01.01.2018)
Published in Annals of oncology (01.01.2018)
Get full text
Journal Article
A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results
Pivot, X., Bondarenko, I., Nowecki, Z., Dvorkin, M., Trishkina, E., Ahn, J.-H., Im, S.-A., Sarosiek, T., Chatterjee, S., Wojtukiewicz, M.Z., Shparyk, Y., Moiseyenko, V., Bello, M., Semiglazov, V., Lee, Y., Lim, J.
Published in European journal of cancer (1990) (01.04.2018)
Published in European journal of cancer (1990) (01.04.2018)
Get full text
Journal Article
A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer
Ajani, J.A., Abramov, M., Bondarenko, I., Shparyk, Y., Gorbunova, V., Hontsa, A., Otchenash, N., Alsina, M., Lazarev, S., Feliu, J., Elme, A., Esko, V., Abdalla, K., Verma, U., Benedetti, F., Aoyama, T., Mizuguchi, H., Makris, L., Rosati, G.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
A randomised, phase II study of nintedanib or sunitinib in previously untreated patients with advanced renal cell cancer: 3-year results
Eisen, T, Loembé, A-B, Shparyk, Y, MacLeod, N, Jones, R J, Mazurkiewicz, M, Temple, G, Dressler, H, Bondarenko, I
Published in British journal of cancer (20.10.2015)
Published in British journal of cancer (20.10.2015)
Get full text
Journal Article
2509 Overall survival analysis from a randomised phase III trial of axitini vs sorafenib as first-line therapy in patients with metastatic renal cell carcinoma
Hutson, T.E, Al-Shukri, S, Stus, V.P, Lipatov, O.N, Shparyk, Y, Bair, A.H, Rosbrook, B, Andrews, G.I, Vogelzang, N.J
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-Neulasta® in the prophylactic treatment of chemotherapy-induced neutropenia
Waller, C, Blakeley, C, Pennella, E, Bronchud, M.H, Mattano, L, Berzoy, O, Voitko, N, Adamchuk, H, Zautashvili, Z, Vinnyk, Y, Nemsadze, G, Dzagnidze, G, Shparyk, Y, Lytvyn, I, Rusyn, A, Popov, V, Láng, I, Sharma, R, Baczkowski, M, Kothekar, M
Published in European journal of cancer (1990) (01.02.2017)
Published in European journal of cancer (1990) (01.02.2017)
Get full text
Journal Article
1866 First results from the double-blind placebo (PL)-controlled randomised phase III MERiDiAN trial prospectively evaluating plasma (p)VEGF-A in patients (pts) receiving first-line paclitaxel (PAC) +/- bevacizumab (BV) for HER2-negative metastatic breast cancer (mBC)
Miles, D, Cameron, D, Bondarenko, I, Lyudmila, M, Alcedo, J.C, Lopez, R.I, Im, S.A, Canon, J.L, Shparyk, Y, Yardley, D, Masuda, N, Ro, J, Hubeaux, S, Quah, C, Bais, C, O'Shaughnessy, J
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
1 Avelumab in combination with and/or following chemotherapy vs chemotherapy in treatment-naive patients with ovarian cancer: biomarker analyses from the phase 3 JAVELIN Ovarian 100 trial
Ledermann, J, Colombo, N, Oza, A, Fujiwara, K, Birrer, MJ, Randall, L, Poddubskaya, E, Scambia, G, Shparyk, YV, Lim, MC, Lim, MC, Sohn, J, Yonemori, K, Stewart, RA, Zhang, X, Perkins Smith, J, Linn, C, Monk, BJ
Published in International journal of gynecological cancer (01.11.2020)
Published in International journal of gynecological cancer (01.11.2020)
Get full text
Journal Article
Adjuvant chemotherapy with or without atezolizumab for stage II and III triple-negative breast cancer: final analysis of the ALEXANDRA/ IMpassion030 phase 3 trial
McArthur, H., Bailey, A., Saji, S., El-Abed, S., Nader Marta, G., Metzger, O., Seiller, A., Shparyk, Y., Kim, H.J., Bonichon Lamichhane, N., Alonso, J.L., Ellingson, A., Zimina, A., Yamashita, T., Mohan, S., Shao, Z., Viale, G., Piccart, M., Ignatiadis, M., Gelber, R.
Published in European journal of cancer (1990) (01.03.2024)
Published in European journal of cancer (1990) (01.03.2024)
Get full text
Journal Article
VP11-2021: Trifluridine/tipiracil plus bevacizumab vs capecitabine plus bevacizumab as first line treatment for patients with metastatic colorectal cancer (mCRC) ineligible for intensive therapy: The phase III randomized SOLSTICE study
André, T., Falcone, A., Shparyk, Y., Moiseenko, F.V., Marques, E. Polo, Csoszi, T., Bragagnoli, A. Campos, Liposits, G., Chmielowska, E., Aubel, P., Martín-Fernández, L., Fougeray, R., Causse-Amellal, N., Saunders, M.P.
Published in Annals of oncology (01.02.2022)
Published in Annals of oncology (01.02.2022)
Get full text
Journal Article
P156 - 3-year follow-up of a phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in HER2 positive early or locally advanced breast cancer in neoadjuvant setting
Pivot, X., Bondarenko, I., Dvorkin, M., Sarosiek, T., Wojtukiewicz, M., Shparyk, Y., Kim, Y., Lim, J.
Published in Breast (Edinburgh) (01.03.2019)
Published in Breast (Edinburgh) (01.03.2019)
Get full text
Journal Article
3-year follow-up of a phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in HER2 positive early or locally advanced breast cancer in neoadjuvant setting
Pivot, X., Bondarenko, I., Dvorkin, M., Sarosiek, T., Wojtukiewicz, M., Shparyk, Y., Kim, Y., Lim, J.
Published in Breast (Edinburgh) (01.03.2019)
Published in Breast (Edinburgh) (01.03.2019)
Get full text
Journal Article
140O Veliparib plus carboplatin-paclitaxel in patients with HER2-negative advanced/metastatic gBRCA-associated breast cancer: Results in hormone receptor-positive and triple-negative breast cancer subgroups from the phase III BROCADE3 trial
Ayoub, J-P., Friedlander, M.L., Dieras, V.C., Wildiers, H., Arun, B., Han, H.S., Puhalla, S., Shparyk, Y., Jakobsen, E.H., Kundu, M.G., Wu, M., Ratajczak, C., Maag, D., Kaufman, B.
Published in Annals of oncology (01.05.2020)
Published in Annals of oncology (01.05.2020)
Get full text
Journal Article
Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer
Diéras, V.C., Han, H.S., Kaufman, B., Wildiers, H., Friedlander, M., Ayoub, J.-P., Puhalla, S.L., Bondarenko, I., Campone, M., Jakobsen, E.H., Jalving, M., Oprean, C., Palácová, M., Park, Y.H., Shparyk, Y., Yañez, E., Dudley, M., Ratajczak, C.K., Maag, D., Arun, B.K.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
LBA9 - Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer
Diéras, V.C., Han, H.S., Kaufman, B., Wildiers, H., Friedlander, M., Ayoub, J.-P., Puhalla, S.L., Bondarenko, I., Campone, M., Jakobsen, E.H., Jalving, M., Oprean, C., Palácová, M., Park, Y.H., Shparyk, Y., Yañez, E., Dudley, M., Ratajczak, C.K., Maag, D., Arun, B.K.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article